Structured JSON API for this factor page: https://sharemaestro.com/factors/api/tickers/1fb145eb-ecf0-437d-aca4-b7a6e873807b/
LKFT
Lakefront Biotherapeutics NVSnapshot 2026-06-07 · 0.0w · Fresh
Strategy Eligibility
7 of 23 passing
★
OS Composite
OS 0.860
↗
Trending Value
✗
◆
Quality × Value
QV 0.808
🏛
Cornerstone Value
✗
🌿
Cornerstone Growth
✗
💎
Deep Value
P/E 3.8
◇
VC2 Cheapest
✗
📐
EBITDA/EV
22.4%
◐
Veiled Value
✗
▣
Piotroski Bargains
✗
🔬
Quality Compounders
ROE 15%
📈
Consistent Earners
✗
🌱
GARP
Rev +304%
🔄
Shareholder Yield
✗
💰
High Yield
✗
🚀
Momentum Leaders
✗
◉
Market Leaders
✗
◎
Tiny Titans
✗
🔍
Small Cap Value
Val 92th
🛡
Low Volatility
✗
🏷
Sector Cheapest
✗
🧠
Capital Allocators
✗
⚡
Risk-Adj Momentum
✗
V
Value Analysis
Cheapness relative to fundamentals
92.0%ile
P/E
3.8×
P/S
1.8×
P/B
0.6×
E/P
0.2648
FCF Yield
-0.164
EBITDA/EV
0.224
SH Yield
0.000
Relative Strength Across Value Dimensions
Multiples & Yields — Decomposition
VC1 (5-Factor)
7.00000000
/100 — 1=cheapest
VC2 (Trending Value)
12.00000000
/100
VC3 (Buyback)
12.00000000
/100
P/E of 3.8x places this firmly in deep value territory. Negative FCF yield (-16.4%) — the business is currently cash-consumptive.
Q
Quality Analysis
Profitability, efficiency, balance sheet & earnings quality
71.0%ile
ROE
0.150
ROA
0.145
Net Margin
0.468
Op Margin
0.571
GPA
0.303
D/E
0.04
Current
30.48
F-Score
6/9
Quality Radar — Relative Strength
Profitability & Leverage Breakdown
Rev Growth
3.035
Earn Growth
3.331
Stability
6.079
lower=better
Accruals
0.234
lower=better
5yr Consist
No
Conservative balance sheet with D/E of 0.04. Accruals ratio of 0.234 is elevated — earnings quality may be lower than headline numbers suggest.
M
Momentum & Risk
Price trend, volatility regime, risk-adjusted returns
24.0%ile
6M Return
-11.3%
12M Return
1.0%
12-1 Mom
3.1%
Risk-Adj
0.12
Vol 252d
27.0%
Vol 60d
60.9%
↑ Expanding
Max DD 12M
-28.1%
Return Comparison — 6M / 12M / 12-1
Volatility Regime — 60d vs 252d
Near-term vol (61%) is expanding vs long-term (27%) — risk is increasing.
OS
Composite & Factor Heatmap
All factors at a glance
0.86
Pillar Balance — Value / Quality / Momentum
Factor Heatmap — green=strong, red=weak
▦
Sector Context
Healthcare
· 500 peers
Sector Value %ile
96.6%
Sector Quality %ile
82.6%
P/E z-score
-0.39
P/B z-score
-0.37
Sector Avg OS
63.2%
Ticker vs Sector Averages
Relative Valuation Z-Score
Top Sector Peers (By OS)
Factor Interactions
Value + Quality Intersection
Top-tier on both cheapness (92th) and quality (71th) — the O'Shaughnessy sweet spot, historically the strongest long-term combination.
Growth at Reasonable Price
Revenue growing 304% with P/E of 4×. Growth isn't fully priced in.
Earnings Quality Concern
ROE looks strong (15%) but high accruals (0.234) suggests earnings are accrual-heavy, not cash-backed.
Volatility Expanding
60-day vol (61%) significantly exceeds 252-day (27%). Near-term risk is elevated.
⚖
Factor Analysis
Comprehensive factor intelligence — strengths, weaknesses & cross-factor profile
Value
B
71.5% avg (7 factors)
Quality
B
71.9% avg (8 factors)
Momentum
D
30.8% avg (4 factors)
Risk
B
71.7% avg (1 factors)
This stock sits in the O'Shaughnessy sweet spot — cheap AND high quality. Historically, this combination has generated the strongest long-term returns. Momentum is weak, suggesting the market isn't yet buying this thesis. Patience required.
▲ Top Strengths — highest scoring factors
▼ Key Weaknesses — lowest scoring factors
Factor Persistence1 snapshots
| Factor | Current | Streak | Trend | Spark |
|---|---|---|---|---|
| OS Composite | 0.860 | —1 | — | |
| Value %ile | 0.920 | —1 | — | |
| Quality %ile | 0.710 | —1 | — | |
| Momentum %ile | 0.240 | —1 | — | |
| F-Score | 6.000 | —0 | — | |
| Confidence | 0.970 | —1 | — | |
| Volatility | 0.270 | —0 | — |
Value FactorsCheapness relative to fundamentals — lower multiples = cheaper
P/E Ratio
3.78
Earnings Yield (E/P)
0.2648
Price / Sales
1.77
Price / Book
0.57
FCF Yield
-16.4%
EBITDA / EV
22.4%
Sales Yield (1/P·S)
0.5862
Shareholder Yield
Div + net buyback / mktcap
0.0%
Quality FactorsProfitability, efficiency, and balance sheet strength
Return on Equity
15.0%
Return on Assets
14.5%
Net Margin
46.8%
Operating Margin
57.1%
Gross Profit / Assets
Novy-Marx GPA
30.3%
Debt / Equity
0.04
Current Ratio
30.48
Accruals Ratio
(NI-OCF)/Assets — lower=better
0.234
MomentumPrice trend strength over different horizons
6M Return
-11.3%
12M Return
1.0%
12-1 Momentum
Jegadeesh-Titman (skip recent month)
3.1%
Risk-Adjusted Momentum
Mom 12-1 ÷ Vol
0.12
Growth & StabilityEarnings trajectory, consistency, and capital allocation
Revenue Growth (YoY)
303.5%
Earnings Growth (YoY)
333.1%
Earnings Stability (CV)
Lower = more stable
6.079
5yr Consistent
EPS up every year for 5 years
No
Piotroski F-Score
6
Dividend Yield
0.0%
Buyback Yield
0.0%
O'Shaughnessy CompositesValue Composites (WWOWS 4th Ed) — 1=cheapest, 100=most expensive
VC1 (5-factor)
P/E+P/S+P/B+P/CF+EBITDA/EV
7
VC2 (6-factor)
VC1 + Shareholder Yield — used for Trending Value
12
VC3 (6-factor)
VC1 + Buyback Yield — no dividend preference
12
Capital Allocation & AlphaAlpha within factors — quality of management decisions
Veiled Value
Expensive by P/B, cheap by everything else
No
Market Leader
Above-avg mcap+revenue, non-utility
No
All Stocks Universe
Market cap > $200M
Yes
Tiny Titan
Micro-cap, low P/S, positive momentum
No
Quarterly Fundamentals
Revenue
Net Income
FCF
Net Margin
Show all
Op Income
OCF
CapEx
Equity
Annual Fundamentals
Revenue
Net Income
FCF
Net Margin
Show all
Op Income
OCF
CapEx
Equity